Exercise thallium-201 (201Tl) myocardial scans were obtained in 102 patients undergoing diagnostic coronary arteriography, of whom 59 showed more than 70% narrowing of one or more of the coronary arteries, 8 showed 50–70% narrowing of one vessel, and 35 had normal coronary arteriograms. Among the 59 patients with coronary artery disease, the exercise ECG was positive in 33 (55%) and the exercise 201Tl was abnormal in 45 (76%). 52 of these 59 patients (91%) had either an abnormal exercise 201Tl or a positive exercise ECG or both (p < 0.001 compared to exercise ECG). The exercise ECG was inconclusive in 17 patients and among those, the exercise 201Tl correctly identified 13 cases (76%). Of 29 patients with a normal left ventriculogram, 17 (58%) showed abnormal exercise 201Tl, 28 of 30 patients (93%) with abnormal left ventriculograms showed an abnormal myocardial scan (p < 0.05). 23 of 25 patients (92%) with collateral circulation had abnormal exercise 201Tl compared with 22 of 34 patients (64%) without collateral circulation (p < 0.05). Among 35 patients with normal coronary arteriogram, 5 (15%) had abnormal exercise 201Tl; 4 of them also had positive exercise ECGs, and 2 showed prolapse of the mitral valve angiographically. 14 patients in this group had inconclusive exercise ECGs; and the exercise 201Tl correctly identified 13 of them (92%). We conclude that (1) exercise 201Tl improves the diagnostic value of exercise ECG; (2) the left ventriculogram and collateral circulation show a significant correlation with the incidence of abnormal exercise 201Tl; (3) false-negative exercise 201 Tl is observed predominantly in patients with disease limited to the secondary branches of the left coronary system, and (4) false-positive exercise 201Tl can be encountered in patients with prolapse of the mitral valve and with normal coronary arteriograms.

Keywords:
Coronary artery disease, Thallium-201 myocardial perfusion scan, Exercise electrocardiogram
This content is only available via PDF.
© 1980 S. Karger AG, Basel
1980
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.